Single inhaler therapy vs fixed dose ICS
Single inhaler therapy showed no clear difference in serious adverse events (non‐fatal) compared with fixed dose ICS (moderate certainty).
- Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including… 2013 · Cochrane Headline outcomes onlyOR 0.97 [0.73, 1.29]3 studies · 4209 participantsModerate